Diagnosis and management of group B streptococcus in pregnancy

Homa K Ahmadzia1, R Phillips Heine1

  • 1Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Medical Center, DUMC 3967, Durham, NC 27710, USA.

Insights

Group B Streptococcus (GBS) screening and treatment guidelines have significantly reduced neonatal sepsis in the US. This article reviews GBS clinical management, from screening and diagnosis to current and future peripartum therapies.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Health
  • Infectious Diseases

Background:

  • Group B Streptococcus (GBS) is a major cause of maternal and neonatal morbidity.
  • US Centers for Disease Control and Prevention (CDC) guidelines have been implemented over 30 years.
  • These guidelines focus on antepartum screening and intrapartum treatment to prevent GBS transmission.

Purpose of the Study:

  • To review the clinical implications of GBS in the peripartum period.
  • To highlight current screening, diagnosis, and prophylactic interventions for GBS.
  • To discuss potential future therapies for managing GBS.

Main Methods:

  • Literature review of GBS management strategies.
  • Analysis of the impact of CDC guidelines on neonatal sepsis rates.
  • Synthesis of information on clinical management and emerging therapies.

Main Results:

  • Significant reductions in early-onset GBS neonatal sepsis observed in the United States.
  • Established effectiveness of antepartum screening and intrapartum treatment protocols.
  • Identification of areas for continued research and therapeutic development.

Conclusions:

  • Current GBS management strategies have proven effective in reducing neonatal morbidity.
  • Continued adherence to screening and treatment guidelines is crucial.
  • Further research into novel therapies may offer enhanced protection against GBS.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
524
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
763
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
3
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
943
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
48
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.9K